Immucell CORP /DE/ DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
ImmuCell Corporation is holding its Annual Meeting of Stockholders on June 11, 2026, to elect directors, vote on executive compensation, approve stock plans, amend its charter, and ratify its accounting firm.
NASDAQ
ImmuCell Corporation will hold its Annual Meeting of Stockholders remotely on June 12, 2025, to vote on director elections, executive compensation, a stock option plan amendment, and the ratification of the independent accounting firm.
NASDAQ
ImmuCell Corporation will hold its Annual Meeting of Stockholders remotely on June 13, 2024, to elect directors, vote on executive compensation, and ratify the appointment of its independent accounting firm.